Financials • Specialty Insurers
$268.20 ▲ +7.78
(+2.99%)
MKT CAP: $68.74B • VOL: 2.50M
52W L $191 52W H $277
AJG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $13.94B | $11.55B | $10.07B |
| YoY Revenue Growth % | +20.7% | +14.7% | — |
| Gross Profit | $6.13B | $5.08B | $4.43B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.76B | $1.73B | $1.14B |
| Operating Margin % | 12.6% | 14.9% | 11.4% |
| Net Income (GAAP) | $1.49B | $1.46B | $970.0M |
| EBITDA (Normalized) | $2.26B | $2.14B | $1.51B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.93B | $2.58B | $2.03B |
| Capital Expenditures (CapEx) | $627.4M | $520.0M | $453.2M |
| Free Cash Flow (FCF) | $1.30B | $2.06B | $1.58B |
| FCF Margin % | 9.3% | 17.9% | 15.7% |
| Return on Invested Capital (ROIC %) | 5.0% | 5.3% | 4.0% |
| Cash & Short-Term Equivalents | $7.77B | $7.07B | $4.16B |
| Total Debt (Short + Long Term) | $12.10B | $12.73B | $8.85B |
| Total Stockholders' Equity | $23.32B | $20.15B | $18.15B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR AJG.